Human Milk Oligosaccharides Market: By Product; By Type; By Applications & By Geography - Forecast 2017-2023

  • ID: 4532518
  • Report
  • 140 pages
  • IndustryARC
1 of 3
“Human Milk oligosaccharides (HMOs)” are collectively called a structure of diverse unconjugated glycan’s that are found in and distinct to human breast milk, despite not actually digestible by human infants. HMOs activity as a prebiotic are favoring to initiate commensal bacteria. HMOs also work as anti-adhesives that intercept the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are prepared by numerous processes which necessitates the usage of several chemicals, enzymes and microbes. The human milk oligosaccharides technology is very difficult and costly, therefore is their large scale production. Key players in the industry have been raising investments on R&D for low-cost production and the initiation of new technologies for product synthesis. The net market for Human Milk oligosaccharides (HMOs) is estimated to be $XX billion in 2016 and is forecast to cross $XX billion by 2023 with a CAGR of $XX% between 2017 and 2023.

Human Milk Oligosaccharides (HMOs) Market

Growing innovation of new technologies in “Human Milk oligosaccharides (HMOs)” is increasing the demand for Human Milk oligosaccharides (HMOs) globally. The market for Human Milk oligosaccharides (HMOs) is analyzed by various regions through its applications such as Food & Beverages, Food Supplements and others.

The market for “Human Milk oligosaccharides (HMOs)” is segmented by regions into North America, Europe, Asia-Pacific and Rest of the World. Key market players are profiled with attributes of company overview, business strategies and product portfolio.

Sample companies profiled in this report are:
Elicityl S.A.

Glycom A/S
Glycosyn LLC
10+.
Note: Product cover images may vary from those shown
2 of 3
1. Human Milk Oligosaccharides (HMO) Market Overview

2. Human Milk Oligosaccharides (HMO) Market- Executive Summary

3. Human Milk Oligosaccharides (HMO) Market Landscape
3.1. Market Share Analysis
3.2. Competitive analysis
3.2.1. Product Benchmarking
3.2.2. End-User Profiling
3.2.3. Patent analysis
3.2.4. Top 5 Financials Analysis

4. Human Milk Oligosaccharides (HMO) Market Forces
4.1. Market Drivers
4.2. Market Constraints/Challenges
4.3. Attractiveness of the Global Human Milk Oligosaccharides (HMO) Industry
4.3.1. Power of Suppliers
4.3.2. Power of Customers
4.3.3. Threat of New entrants
4.3.4. Threat of Substitution
4.3.5. Degree of Competition

5. Human Milk Oligosaccharides (HMO) Market- Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product/Market Life Cycle

6. Human Milk Oligosaccharides (HMO) Market - By Product
6.1. Introduction
6.2. Lacto-N-neotetraose (LNnT)
6.3. Lacto-N-tetraose (LNT)
6.4. 2'-Fucosyllactose (2'FL)
6.5. 3'-Fucosyllactose (3'FL)
6.6. 3'-Sialyllactose (3'SL)
6.7. 6'-Sialyllactose (6'SL)
6.8. Others

7. Human Milk Oligosaccharides (HMO) Market - By Type
7.1. Introduction
7.2. Neutral
7.3. Acidic
7.4. Others

8. Human Milk Oligosaccharides (HMO) Market- By Applications
8.1. Introduction
8.2. Food & beverages
8.3. Food supplements
8.4. Infant formulas
8.5. Others

9. Human Milk Oligosaccharides (HMO) Market- By Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. U.K.
9.3.2. France
9.3.3. Germany
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. APAC
9.4.1. China
9.4.2. India
9.4.3. Japan
9.4.4. Australia & New Zealand
9.4.5. South Korea
9.4.6. Rest of APAC
9.5. RoW
9.5.1. Middle East
9.5.2. South America
9.5.3. Africa

10. Human Milk Oligosaccharides (HMO) Market Entropy

11. Human Milk Oligosaccharides (HMO) Market - Company Profiles
11.1. company 1
11.2. company 2
11.3. company 3
11.4. company 4
11.5. company 5
11.6. company 6
11.7. company 7
11.8. company 8
11.9. company 9
11.10. Company 10
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"

12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll